IATDMCT 2017

セッション情報

印刷

Poster

[P26-5] P26-5: Immunosuppressive drugs (4): Individualized dosage adjustment

2017年9月26日(火) 12:30 〜 13:30 Annex Hall (1F)

Chair: Kohshi Nishiguchi, Japan

[P26-5-1] Overweight kidney transplant recipients are at risk of being overdosed following standard bodyweight-based tacrolimus dosing

Louise M. Andrews1, Brenda CM de Winter2, Jiang-Tao Tang3, Nauras Shuker4, Rachida Bouamar5, Ron Hn Van Schaik6, Birgit C.P. Koch7, Teun van Gelder8, Dennis A. Hesselink9 (1.Erasmus MC, 2.Erasmus MC, 3.West China Hospital of Sichuan University, 4.Erasmus MC, 5.Erasmus MC, 6.Erasmus MC, 7.Erasmus MC, 8.Erasmus MC, 9.Erasmus M)

[P26-5-3] Overweight and underweight kidney transplant recipients at risk of being underdosed or overdosed following standard tacrolimus dosing

Jiang-Tao Tang1, Yun-Ying Shi2, Yi Li3, Yuan-Gao Zou4, Yang-Juan Bai5, Lan-Lan Wang6 (1.West China Hospital of Sichuan University, 2.West China Hospital of Sichuan University, 3.West China Hospital of Sichuan University, 4.West China Hospital of Sichuan University, 5.West China Hospital of Sichuan University, 6.West China Hospital of Sichuan University)

[P26-5-4] Twenty-four hour tacrolimus pharmacokinetics in renal transplant recipients on twice-daily dosing

Marte Theie Gustavsen1, Karsten Midtvedt2, Ida Robertsen3, Rolf Klaasen4, Elisabet Storset5, Erlend Johannessen Egeland6, Stein Bergan7, Nils Tore Vethe8, Anders Aasberg9 (1.Oslo University Hospital Rikshospitalet, 2.Oslo University Hospital Rikshospitalet, 3.University of Oslo, 4.Oslo University Hospital, 5.Oslo University Hospital Rikshospitalet, 6.University of Oslo, 7.Oslo University Hospital, 8.Oslo University Hospital, 9.Oslo University Hospital Rikshospitalet)

[P26-5-5] High tacrolimus clearance and acute rejection risk after renal transplantation

Erlend Johannessen Egeland1, Ida Robertsen2, Monica Hermann3, Karsten Midtvedt4, Elisabet Stoerset5, Marte Theie Gustavsen6, Anna Varberg Reisaeter7, Rolf Klaasen8, Stein Bergan9, Hallvard Holdaas10, Anders Hartmann11, Anders Aasberg12 (1.University of Oslo, 2.University of Oslo, 3.Western Norway University of Applied Sciences, 4.Oslo University Hospital, 5.Oslo University Hospital, 6.University of Oslo, 7.Oslo University Hospital, 8.Oslo University Hospital, 9.Oslo University Hospital, 10.Oslo University Hospital, 11.Oslo University Hospital, 12.Oslo University Hospital)

[P26-5-6] Survival time to biopsy-proven acute rejection in pediatric liver transplant patients

Natalia Riva1, Paulo Caceres Guido2, Debora Chan3, Jean-Baptiste Woillard4, Jefferson Buendia5, Nieves Licciardone6, Pierre Marquet7, Marcelo Dip8, Oscar Imventarza9, Paula Schaiquevich10 (1.Hospital de Pediatria JP Garrahan, 2.Hospital de Pediatria JP Garrahan, 3.Hospital de Pediatria JP Garrahan, 4.CHU Limoges, 5.Antioquia University, 6.Hospital de Pediatria JP Garrahan, 7.CHU Limoges, 8.Hospital de Pediatria JP Garrahan, 9.Hospital de Pediatria JP Garrahan, 10.Hospital de Pediatria JP Garrahan)

[P26-5-7] Sublingual tacrolimus administration: experience in pediatric liver transplant patients

Natalia Riva1, Maria Eugenia Galvan2, Paulo Caceres Guido3, Erika Perez4, Marcelo Dip5, Nieves Licciardone6, Oscar Imventarza7, Daniel Buamscha8, Paula Schaiquevich9 (1.Hospital de Pediatria JP Garrahan, 2.Hospital de Pediatria JP Garrahan, 3.Hospital de Pediatria JP Garrahan, 4.Hospital de Pediatria JP Garrahan, 5.Hospital de Pediatria JP Garrahan, 6.Hospital de Pediatria JP Garrahan, 7.Hospital de Pediatria JP Garrahan, 8.Hospital de Pediatria JP Garrahan, 9.Hospital de Pediatria JP Garrahan)